// App-Quantinova.ai

OR5‐029 : A novel thrombomodulin gene variant leading to hyperthrombomodulinaemia and a hereditary bleeding disorder

Researchers

Presenter

  • A-L Latif

Principal Investigators

  • K Downes

  • NJ Mutch

  • E Leishman

  • K Gomez

  • SVV Deevi

  • K Megy

  • CS Whyte

  • RC Tait

Medical Centers

  • Haematology, Glasgow Royal Infirmary, Glasgow

  • Department of Psychology, University of Cambridge, Cambridge

  • School of Medicine, University of Aberdeen, Aberdeen

  • Cambridge Biomedical Campus, University of Cambridge, Cambridge

  • Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free London NHS Foundation Trust, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Musculoskeletal

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Thrombomodulin alfa

  • Protein C

  • Evithrom

  • Trypsin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved